Rocco Venezia - 31 Dec 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
Chief Accounting Officer
Signature
/s/ Rocco Venezia
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$8,960
Form type
4
Filing time
04 Jan 2022, 15:18:13 UTC
Previous filing
05 Oct 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $8,389 -515 -3.8% $16.29 13,190 31 Dec 2021 Direct F1
transaction ICPT Common Stock Tax liability $570 -35 -0.27% $16.29 13,155 01 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.